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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORFulminant type 1 diabetes during pregnancy in
Chinese patientsTable 1 Biochemical laboratory examinations of two pa-
tients on admission.
Variables Case 1 Case 2
Urinalysis
Glucose (þþ) (þþ)
Ketone (þþ) (þþ)
Protein (þ) ()
Occult (þþ) (þþþ)
CBC
WBC (/L) 17.3  109 41.3  109
RBC (/L) 4.9  1012 4.2  1012
Hb (g/L) 142 133
Plt (/L) 438  109 387  109
Blood gas analysis
pH 7.0 6.9
pO2 (mmHg) 104.6 76.9
pCO2 (mmHg) 11.3 11.9
HCO3
(mmol/L) 5.7 4.8
BE (mmol/L) 26.8 29.8
Blood chemistry
Glu (mmol/L) 30.7 48.7
HbA1c (%) 5.7 6.5
TP (g/L) 87 56.3
Alb (g/L) 47.0 31.8
T-bil (mmol/L) 13.6 7.3Dear Editor,
Fulminant type 1 diabetes (FT1DM) is classified as a subtype
of the nonautoimmune type 1 diabetes, characterized by its
clinical features of abrupt onset with ketosis or ketoaci-
dosis and virtually no C-peptide secretion [1,2]. FT1DM
development during pregnancy may result in severe com-
plications for both mother and fetus. To date, most of the
patients with FT1DM during pregnancy have been reported
in Japan [2]; a few cases have been reported in Korea,
Malaysia, France, Taiwan [3], and mainland China [4]. Here,
we report two cases of FT1DM during pregnancy seen in our
hospital, which presented fetal demise.
The first woman, aged 23 years, presented with nausea
and vomiting for 1 day without hyperglycemic symptoms at
32 weeks’ gestation. The second case was a 21-year-old
woman at 25 weeks’ gestation, who had excessive thirst,
polyuria, and fever for 3 days. The two patients consulted
our hospital on feeling reduced fetal movements. Based on
the blood and urinary examinations (Table 1), both of them
were diagnosed with diabetic ketoacidosis (DKA), caused by
FT1DM. The two patients were treated with intravenous
insulin injections and a large volume of intravenous normal
saline administration for DKA. Antibiotics were used to
control the upper respiratory tract infection in the second
case. Metabolic acidosis was controlled within 3 days.
Multiple insulin injections were administered for blood
glucose control. Although the two patients were treated
successfully, fetal demise occurred in both cases. Both of
them were followed up in the outpatient department with
multiple insulin injections.
A previous nationwide survey in Japan reported that
almost all female patients who developed type 1 diabetes
during pregnancy appeared to have FT1DM [2]. A nation-
wide investigation in China also suggested that the onset of
this disease was associated with pregnancy in some pa-
tients. The clinical and laboratory findings of the two cases
reported here were in accord with the diagnostic criteria ofConflict of Statement: The authors have no conflicts of interest
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countries other than Japan. These reports suggest that this
disease is not a clinical entity specific to Japanese women,
but can occur in pregnant women in other countries too.
FT1DM developed during pregnancy may result in severe
complications for both mother and fetus due to the sudden
onset and severity of maternal DKA [5]. Fetal mortality was
reported to be as high as 67% [5]. In these two cases,
although the two pregnant women were treated success-
fully, fetal demise occurred. Previous studies suggest thatALT (IU/L) 15 25
AST (IU/L) 31 25
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Table 1 (continued )
Variables Case 1 Case 2
ALP (IU/L) 164 51
BUN (mmol/L) 9.8 13.6
Cr (mmol/L) 63.7 96.0
Na (mmol/L) 130.7 116.6
K (mmol/L) 5.7 8.3
Cl (mmol/L) 94.0 81.9
T-cho (mmol/L) 9.1 6.2
TG (mmol/L) 8.3 10.3
Amy (IU/L) 84 73
Lipase (IU/L) 58 123
Antibodies
Anti-GAD antibody () ()
Islet-cell antibody () ()
IAA antibody () ()
Endocrine examination
Fasting serum C-peptide
(nmol/L)
Below 0.01 Below 0.05
Postprandial serum
C-peptide (nmol/L)
0.02 Below 0.05
Glucagon loading test
(nmol/L)
(0 min) 0.01
(6 min) 0.01
WBC Z white blood cell count; RBC Z red blood cell count;
HbZ hemoglobin; PltZ platelets; PHZ potential of hydrogen;
BE Z base excess; Glu Z glucose; HbA1c Z hemoglobin A1c;
TP Z total protein; Alb Z albumin; T-bil Z total bilirubin;
ALT Z alanine aminotransferase; AST Z aspartate amino-
transferase; ALP Z alkaline phosphatase; BUN Z blood urea
nitrogen; Cr Z creatinine; T-cho Z total cholesterol;
TG Z total triglycerides.
162 Letter to the Editorsome characteristic symptoms, such as thirst, common-
cold-like symptoms, and abdominal symptoms, may pre-
cede the onset of FT1DM [2]. Patients who developed
FT1DM during pregnancy shared similar characteristics,
such as high a frequency of common-cold-like symptoms
and hyperglycemic symptoms [5]. The two patients re-
ported here also presented with hyperglycemic or abdom-inal symptoms. However, both of them consulted our
hospital on feeling reduced fetal movements. Therefore,
all physicians as well as obstetricians should pay attention
and not overlook the presence of ketoacidosis caused by
this type of diabetes if a pregnant woman abruptly exhibits
hyperglycemic, common-cold-like, or abdominal symp-
toms. The treatment for DKA should be carried out imme-
diately after its development. Awareness of all medical
practitioners and patients about this disease can lead to
prompt diagnosis and emergency treatment and, conse-
quently, improved maternal and fetal prognosis.
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